Catalyst Wire Dossier Catalyst Wire Dossier

Indium In-111 Oxine

Indium-111 oxine · Medi-Physics Inc. dba GE Healthcare
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Indium In-111 Oxine, covering 2022-12-12 to 2022-12-12. Get the full timeline:

Most recent: FDA Approved: INDIUM IN 111 OXYQUINOLINE — Supplemental Application (Medi-Physics Inc. dba GE Healthcare.)

See pricing